[1] |
Pesonen M, Koskela K, Aalto⁃Korte K. Contact urticaria and protein contact dermatitis in the Finnish Register of Occupational Diseases in a period of 12 years[J]. Contact Dermatitis, 2020,83(1):1⁃7. doi: 10.1111/cod.13547.
|
[2] |
Carøe TK, Ebbehøj NE, Bonde JP, et al. Occupational hand eczema and/or contact urticaria: factors associated with change of profession or not remaining in the workforce[J]. Contact Dermatitis, 2018,78(1):55⁃63. doi: 10.1111/cod.12869.
|
[3] |
Aquino M, Mawhirt S, Fonacier L. Review of contact urticaria syndrome—evaluation to treatment[J]. Curr Treat Options Allergy, 2015,2(4):365⁃380. doi: 10.1007/s40521⁃015⁃0068⁃7.
|
[4] |
Orb Q, Millsop JW, Harris K, et al. Prevalence and interest in the practice of scratch testing for contact urticaria: a survey of the American contact dermatitis society members[J]. Dermatitis, 2014,25(6):366⁃369. doi: 10.1097/DER.00000000 00000086.
|
[5] |
Süß H, Dölle⁃Bierke S, Geier J, et al. Contact urticaria: frequency, elicitors and cofactors in three cohorts (Information Network of Departments of Dermatology; Network of Anaphylaxis; and Department of Dermatology, University Hospital Erlangen, Germany)[J]. Contact Dermatitis, 2019,81(5):341⁃353. doi: 10.1111/cod.13331.
|
[6] |
Amaro C, Goossens A. Immunological occupational contact urticaria and contact dermatitis from proteins: a review[J]. Contact Dermatitis, 2008,58(2):67⁃75. doi: 10.1111/j.1600⁃0536.2007.01267.x.
|
[7] |
Walter A, Seegräber M, Wollenberg A. Food⁃related contact dermatitis, contact urticaria, and atopy patch test with food[J]. Clin Rev Allergy Immunol, 2019,56(1):19⁃31. doi: 10.1007/s12016⁃018⁃8687⁃y.
|
[8] |
Gomułka K, Panaszek B. Contact urticaria syndrome caused by haptens[J]. Postepy Dermatol Alergol, 2014,31(2):108⁃112. doi: 10.5114/pdia.2014.40915.
|
[9] |
McFadden J. Immunologic contact urticaria[J]. Immunol Allergy Clin North Am, 2014,34(1):157⁃167. doi: 10.1016/j.iac.2013.09. 005.
|
[10] |
Wilkinson M, Solman L, Coenraads PJ, et al. Immediate hypersensitivity to p⁃phenylenediamine[J]. Contact Dermatitis, 2019,80(3):177⁃178. doi: 10.1111/cod.13156.
|
[11] |
Iwata JI, Inomata N, Sato M, et al. Contact dermatitis with concomitant contact urticaria syndrome due to multiple ingredients of oxidative hair dye[J]. Allergol Int, 2019,68(1):114⁃116. doi: 10.1016/j.alit.2018.05.005.
|
[12] |
Bourrain JL, Amblard P, Béani JC. Contact urticaria photoinduced by benzophenones[J]. Contact Dermatitis, 2003,48(1):45⁃46. doi: 10.1034/j.1600⁃0536.2003.480108_1.x.
|
[13] |
Haisma MS, Schuttelaar ML. Contact urticaria caused by the ultraviolet absorber octocrylene in sunscreens[J]. Contact Dermatitis, 2017,77(4):254⁃256. doi: 10.1111/cod.12806.
|
[14] |
Coelho EQ, Wu S, Nunes RS, et al. Contact urticaria following the use of a cosmetic containing caprylyl glycol: a case report[J]. Contact Dermatitis, 2019,81(4):308⁃309. doi: 10.1111/cod. 13299.
|
[15] |
Sukakul T, Kumpangsin T, Boonchai W. Contact urticaria caused by salicylic acid in a chemical peel solution[J]. Contact Dermatitis, 2020,82(2):121⁃122. doi: 10.1111/cod.13405.
|
[16] |
Sanz⁃Sánchez T, Núñez Acevedo B, Rubio Flores C, et al. Contact urticaria caused by tocopherol[J]. Contact Dermatitis, 2018,79(6):395. doi: 10.1111/cod.13099.
|
[17] |
Verhulst L, Goossens A. Cosmetic components causing contact urticaria: a review and update[J]. Contact Dermatitis, 2016,75(6):333⁃344. doi: 10.1111/cod.12679.
|
[18] |
中国医师协会皮肤科医师分会, 中华医学会皮肤性病学分会, 国家皮肤与免疫疾病临床医学研究中心. 防控冠状病毒感染疾病⁃19医护人员皮肤黏膜屏障防护共识[J]. 中华皮肤科杂志, 2020,53(3):159⁃164. doi: 10.35541/cjd.20200112.
|
[19] |
Japundžić I, Vodanović M, Lugović⁃Mihić L. An analysis of skin prick tests to latex and patch tests to rubber additives and other causative factors among dental professionals and students with contact dermatoses[J]. Int Arch Allergy Immunol, 2018,177(3):238⁃244. doi: 10.1159/000490181.
|
[20] |
Vu M, Rajgopal Bala H, Cahill J, et al. Immediate hypersensitivity to chlorhexidine[J]. Australas J Dermatol, 2018,59(1):55⁃56. doi: 10.1111/ajd.12674.
|
[21] |
Takahagi S, Tanaka A, Iwamoto K, et al. Contact urticaria syndrome with IgE antibody against a cefotiam⁃unique structure, evoked by nonapparent exposure to cefotiam[J]. Clin Exp Dermatol, 2017,42(5):527⁃531. doi: 10.1111/ced.13126.
|
[22] |
Aquino M, Rosner G. Systemic contact dermatitis[J]. Clin Rev Allergy Immunol, 2019,56(1):9⁃18. doi: 10.1007/s12016⁃018⁃8686⁃z.
|
[23] |
Raveendran R. Tips and tricks for controlling eczema[J]. Immunol Allergy Clin North Am, 2019,39(4):521⁃533. doi: 10. 1016/j.iac.2019.07.006.
|
[24] |
Isaac J, Goldminz AM, Scheinman PL. "Pink sign": the importance of short⁃term occlusive testing in suspected cases of contact urticaria[J]. Dermatitis, 2019,30(2):168⁃169. doi: 10. 1097/DER.0000000000000441.
|
[25] |
von Krogh G, Maibach HI. The contact urticaria syndrome⁃⁃an updated review[J]. J Am Acad Dermatol, 1981,5(3):328⁃342. doi: 10.1016/s0190⁃9622(81)70099⁃9.
|
[26] |
闫文萍, 牛莉莉, 张英. 过敏原特异性IgE抗体检测对慢性荨麻疹的诊断价值[J]. 实用检验医师杂志, 2019,11(2):94⁃96. doi: 10.3969/j.issn.1674⁃7151.2019.02.010.
|
[27] |
中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南(2018版)[J]. 中华皮肤科杂志, 2019,52(1):1⁃5. doi: 10.3760/cma.j.issn.0412⁃4030.2019.01.001.
|
[28] |
Jungewelter S, Airaksinen L, Pesonen M. Occupational rhinitis, asthma, and contact urticaria from IgE⁃mediated allergy to pork[J]. Am J Ind Med, 2019,62(1):80⁃84. doi: 10.1002/ajim.22 921.
|
[29] |
Adisesh A, Robinson E, Nicholson PJ, et al. U.K. standards of care for occupational contact dermatitis and occupational contact urticaria[J]. Br J Dermatol, 2013,168(6):1167⁃1175. doi: 10.1111/bjd.12256.
|
[30] |
Chularojanamontri L, Tuchinda P, Pongparit K, et al. Contact urticaria caused by alcohol: clinical characteristics and cross⁃reactions[J]. Ann Allergy Asthma Immunol, 2016,117(6):721⁃723.e1. doi: 10.1016/j.anai.2016.09.434.
|
[31] |
Gimenez⁃Arnau A, Maurer M, De La Cuadra J, et al. Immediate contact skin reactions, an update of contact urticaria, contact urticaria syndrome and protein contact dermatitis ⁃⁃ "a never ending story"[J]. Eur J Dermatol, 2010,20(5):552⁃562. doi: 10.1684/ejd.2010.1049.
|
[32] |
Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of chronic inducible urticarias ⁃ the EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision[J]. Allergy, 2016,71(6):780⁃802. doi: 10.1111/all.12884.
|
[33] |
Nucera E, Mezzacappa S, Buonomo A, et al. Latex immunotherapy: evidence of effectiveness[J]. Postepy Dermatol Alergol, 2018,35(2):145⁃150. doi: 10.5114/ada.2018.75235.
|
[34] |
Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence[J]. J Allergy Clin Immunol, 2018,141(2):638⁃649. doi: 10.1016/j.jaci.2017.06.032.
|
[35] |
Bernstein JA, Kavati A, Tharp MD, et al. Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ′real⁃world′ evidence[J]. Expert Opin Biol Ther, 2018,18(4):425⁃448. doi: 10.1080/14712598.2018.1438406.
|
[36] |
徐艳华, 王菁兰, 王怡玮, 等. 33例141次奥马珠单抗治疗后不良反应回顾性研究[J]. 中华临床免疫和变态反应杂志, 2019,13(6):516⁃519. doi: 10.3969∕j.issn.1673⁃8705.2019.06. 018.
|
[37] |
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria[J]. Allergy, 2018,73(7):1393⁃1414. doi: 10.1111/all.13397.
|
[38] |
陈玉迪, 胡艳, 隋海晶, 等. 抗IgE单克隆抗体在变态反应性疾病治疗中的应用[J]. 中华临床免疫和变态反应杂志, 2018,12(3):302⁃307. doi: 10.3969/j.issn.1673⁃8705.2018.03.008.
|
[39] |
Di Leo E, Calogiuri G, Macchia L, et al. Use of omalizumab in uncontrolled chronic spontaneous urticaria also improved latex⁃induced contact urticaria[J]. J Allergy Clin Immunol Pract, 2019,7(1):300⁃302. doi: 10.1016/j.jaip.2018.05.005.
|